Nobumichi Ohoka

Nobumichi Ohoka

Auto-generated profile, based on publicly available information

Nobumichi Ohoka

Division of Molecular Target and Gene Therapy Products, National Institute of Health Sciences, 3-25-26, Tonomachi, Kawasaki, Kanagawa 210-9501, Japan

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 September 2020 in Antioxidants
Verified
Journal Article
Open access
PDF file
SNSakiko Nishikawa
Sakiko Nishikawa
Yasumichi InoueYasumichi Inoue
Yasumichi Inoue
YHYuka Hori
Yuka Hori
CMChiharu Miyajima
Chiharu Miyajima
DMDaisuke Morishita
Daisuke Morishita
HHHidetoshi Hayashi
Hidetoshi Hayashi
Kurarinone, a flavonoid isolated from the roots of Sophora flavescens, was suggested to exert potent antioxidant and immunosuppressive effects. However, the underlying mechanisms remain unclear. Nuclear factor erythroid 2-related factor 2 (Nrf2) is a key transcription factor that regulates the antioxidant defense system with anti-inflammatory activity. In the present study, we demonstrated that kurarinone activated Nrf2 and increased the expression of antioxidant enzymes, including heme oxygenase-1 (HO-1). Mechanistically, kurarinone downregulated the expression of kelch-like ECH-associated protein 1 (KEAP1), subsequently leading to the activation of Nrf2. Kurarinone also inhibited the expression of the inflammatory cytokine, interleukin (IL)-1β, and inducible nitric oxide synthase (iNos) in lipopolysaccharide (LPS)-stimulated RAW264.7 macrophages. The overexpression of HO-1 suppressed the LPS-induced production of inflammatory mediators in RAW264.7 cells, and the immunosuppressive effects of kurarinone were partially inhibited by a treatment with Tin Protomorphyrin IX (TinPPIX), an inhibitor of HO-1. These results indicate that kurarinone activates the KEAP1/Nrf2 pathway to induce HO-1 expression, thereby exerting immunosuppressive effects.

8 June 2018 in Molecules
Verified
Journal Article
Open access
PDF file
MNMai Nagasaka
Mai Nagasaka
RHRyoko Hashimoto
Ryoko Hashimoto
YIYasumichi Inoue
Yasumichi Inoue
KIKan'ichiro Ishiuchi
Kan'ichiro Ishiuchi
MMMichiyo Matsuno
Michiyo Matsuno
Yasumichi InoueYasumichi Inoue
Yasumichi Inoue
The p53 tumor suppressor plays critical roles in cell cycle regulation and apoptotic cell death in response to various cellular stresses, thereby preventing cancer development. Therefore, the activation of p53 through small molecules is an attractive therapeutic strategy for the treatment of cancers retaining wild-type p53. We used a library of 700 Myanmar wild plant extracts to identify small molecules that induce p53 transcriptional activity. A cell-based screening method with a p53-responsive luciferase-reporter assay system revealed that an ethanol extract of Oroxylum indicum bark increased p53 transcriptional activity. Chrysin was isolated and identified as the active ingredient in the O. indicum bark extract. A treatment with chrysin increased p53 protein expression and the p53-mediated expression of downstream target genes, and decreased cell viability in MCF7 cells, but not in p53-knockdown MCF7 cells. We also found that chrysin activated the ATM-Chk2 pathway in the absence of DNA damage. Hence, the inactivation of the ATM-Chk2 pathway suppressed p53 activation induced by chrysin. These results suggest the potential of chrysin as an anti-cancer drug through the activation of p53 without DNA damage.

17 December 2021 in ACS Medicinal Chemistry Letters
Verified
Journal Article
Closed access
MNMiyako Naganuma
Miyako Naganuma
NONobumichi Ohoka
Nobumichi Ohoka
GTGenichiro Tsuji
Genichiro Tsuji
HTHaruna Tsujimura
Haruna Tsujimura
KMKenji Matsuno
Kenji Matsuno
YDYosuke Demizu
Yosuke Demizu

3 June 2019 in Chemical Communications
Verified
Journal Article
Closed access
PDF file
TMTakashi MISAWA
Takashi MISAWA
NONobumichi Ohoka
Nobumichi Ohoka
MOMakoto Oba
Makoto Oba
HYHiroko Yamashita
Hiroko Yamashita
MTMasakazu Tanaka
Masakazu Tanaka
YDYosuke Demizu
Yosuke Demizu
We have designed and synthesized a set of cell-penetrating foldamers (CPFs), Blocks 1–8, composed of the common amino acids Leu, Arg, and Gly, as well as the helicogenic amino acid 2-aminoisobutyric acid.

19 May 2023 in ACS Medicinal Chemistry Letters
Verified
Journal Article
Closed access
HTHaruna Tsujimura
Haruna Tsujimura
MNMiyako Naganuma
Miyako Naganuma
NONobumichi Ohoka
Nobumichi Ohoka
TITakao Inoue
Takao Inoue
MNMikihiko Naito
Mikihiko Naito
YDYosuke Demizu
Yosuke Demizu

4 November 2022 in ACS Medicinal Chemistry Letters
Verified
Journal Article
Closed access
NONobumichi Ohoka
Nobumichi Ohoka
MSMasanori Suzuki
Masanori Suzuki
TUTakuya Uchida
Takuya Uchida
GTGenichiro Tsuji
Genichiro Tsuji
YTYoshinori Tsukumo
Yoshinori Tsukumo
MNMikihiko Naito
Mikihiko Naito